CLEOCIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cleocin Hydrochloride, and when can generic versions of Cleocin Hydrochloride launch?
Cleocin Hydrochloride is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in CLEOCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-five drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cleocin Hydrochloride
A generic version of CLEOCIN HYDROCHLORIDE was approved as clindamycin hydrochloride by COSETTE on September 20th, 1989.
Summary for CLEOCIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Clinical Trials: | 11 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CLEOCIN HYDROCHLORIDE? | CLEOCIN HYDROCHLORIDE excipients list |
DailyMed Link: | CLEOCIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CLEOCIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Phase 4 |
University of California, Los Angeles | Phase 4 |
Roswell Park Cancer Institute | Phase 4 |
Pharmacology for CLEOCIN HYDROCHLORIDE
Drug Class | Lincosamide Antibacterial |
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLEOCIN HYDROCHLORIDE
US Patents and Regulatory Information for CLEOCIN HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-003 | Apr 14, 1988 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |